Drug Development Insights
Celine discusses the unique challenges of developing drugs in biotech, emphasizing the importance of a solid regulatory strategy and the inherent risks involved. With a focus on their concurrent programs aimed at extending dog lifespan, she highlights the critical need for positive data to validate their approach. The reality of low drug approval rates in pharma underscores the significance of their work, as only a small fraction of drugs successfully navigate clinical trials.In this clip
From this podcast
Newcomer Podcast
Life Extension Innovations, Moonshots & Snake Oil (with Celine Halioua & James Peyer)
Related Questions